Cargando…

Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer

The expression and function of caldesmon (CAD) in urothelial bladder carcinoma (BC) have not been reported. Here, we investigated the expression, prognostic value, and potential functional mechanism of CAD in primary non-muscle-invasive bladder cancer (NMIBC). Protein profiling of tissue samples usi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Myung-Shin, Lee, Jisu, Kim, Joo Heon, Kim, Won Tae, Kim, Wun-Jae, Ahn, Hanjong, Park, Jinsung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741901/ https://www.ncbi.nlm.nih.gov/pubmed/26430961

Ejemplares similares

Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray
por: Lee, Myung-Shin, et al.
Publicado: (2015)

Clinical, prognostic, and therapeutic significance of heat shock protein 27 in bladder cancer
por: Lee, Myung-Shin, et al.
Publicado: (2018)

Radical Cystectomy and Orthotopic Bladder Substitution Using Ileum
por: Park, Jinsung, et al.
Publicado: (2011)

Dexmedetomidine-induced Contraction Involves Phosphorylation of Caldesmon by JNK in Endothelium-denuded Rat Aortas
por: Baik, Jiseok, et al.
Publicado: (2014)

Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis
por: Kim, Yeon Joo, et al.
Publicado: (2017)

Microinjection of nonmuscle and smooth muscle caldesmon into fibroblasts and muscle cells
Publicado: (1990)

Tumor heterogeneity in muscle-invasive bladder cancer
por: Kang, Ho Won, et al.
Publicado: (2020)

Pre-analytical handling conditions and protein marker recovery from urine extracellular vesicles for bladder cancer diagnosis
por: Lee, Jisu, et al.
Publicado: (2023)

Caldesmon ablation in mice causes umbilical herniation and alters contractility of fetal urinary bladder smooth muscle
por: Pütz, Sandra, et al.
Publicado: (2021)

Up-regulated expression of l-caldesmon associated with malignancy of colorectal cancer
por: Kim, Kyung-Hee, et al.
Publicado: (2012)

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer
por: Kim, Sung Min, et al.
Publicado: (2013)

FAM70B as a Novel Prognostic Marker for Cancer Progression and Cancer-Specific Death in Muscle-Invasive Bladder Cancer
por: Kang, Ho-Won, et al.
Publicado: (2012)

Identification of C16orf74 as a Marker of Progression in Primary Non-Muscle Invasive Bladder Cancer
por: Kim, Won Tae, et al.
Publicado: (2010)

GSTT1 as a Prognosticator for Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Seminal Vesicle Involvement by Carcinoma In Situ of the Bladder: Clonal Analysis Using Next-Generation Sequencing to Elucidate the Mechanism of Tumor Spread
por: Park, Hyun Sik, et al.
Publicado: (2020)

Does Radical Cystectomy Improve Overall Survival in Octogenarians with Muscle-Invasive Bladder Cancer?
por: Yoo, Sangjun, et al.
Publicado: (2011)

Suppression of CD81 promotes bladder cancer cell invasion through increased matrix metalloproteinase expression via extracellular signal-regulated kinase phosphorylation
por: Park, Hyun Sik, et al.
Publicado: (2019)

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
por: Kim, Wun-Jae, et al.
Publicado: (2010)

Three-dimensional reconstruction of caldesmon-containing smooth muscle thin filaments
Publicado: (1993)

Caldesmon: Biochemical and Clinical Implications in Cancer
por: Yao, Yi-Bo, et al.
Publicado: (2021)

Decreased DBC1 Expression Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer
por: Shim, Ui Jae, et al.
Publicado: (2013)

GSTM1 Tissue Genotype as a Recurrence Predictor in Non-muscle Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2011)

mRNA Expression of S100A8 as a Prognostic Marker for Progression of Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon
por: Li, Haowen, et al.
Publicado: (2023)

Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle Invasive Bladder Cancer: EORTC QLQ-NMIBC24
por: Park, Jinsung, et al.
Publicado: (2018)

Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression
por: Piao, Xuan-Mei, et al.
Publicado: (2021)

Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability
por: Jiang, Qifeng, et al.
Publicado: (2010)

Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2010)

Novel Combination Markers for Predicting Survival in Patients with Muscle Invasive Bladder Cancer: USP18 and DGCR2
por: Kim, Ye-Hwan, et al.
Publicado: (2014)

A rare case of eosinophilic cystitis involving the inside and outside of the urinary bladder associated with an infected urachal cyst
por: Shin, Hyun Bin, et al.
Publicado: (2021)

Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups
por: Piao, Xuan-Mei, et al.
Publicado: (2022)

Identification by monoclonal antibodies and characterization of human platelet caldesmon
Publicado: (1986)

Localization of caldesmon and its dephosphorylation during cell division
Publicado: (1993)

Predicting Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer in Korean Patients: A Comparison of the EORTC and CUETO Models
por: Choi, Se Young, et al.
Publicado: (2014)

Glucocorticoid receptor-induced non-muscle caldesmon regulates metastasis in castration-resistant prostate cancer
por: Virtanen, Verneri, et al.
Publicado: (2023)

Is Intravesical Bacillus Calmette-Guérin Therapy Superior to Chemotherapy for Intermediate-risk Non-muscle-invasive Bladder Cancer?: An Ongoing Debate
por: Han, Kyung-Sik, et al.
Publicado: (2015)

Stretch Activates Human Myometrium via ERK, Caldesmon and Focal Adhesion Signaling
por: Li, Yunping, et al.
Publicado: (2009)

Essential role of caldesmon in the actin filament reorganization induced by glucocorticoids
Publicado: (1995)

Perioperative immunotherapy for muscle-invasive bladder cancer
por: Kim, In-Ho, et al.
Publicado: (2020)

Overexpression of human fibroblast caldesmon fragment containing actin- , Ca++/calmodulin-, and tropomyosin-binding domains stabilizes endogenous tropomyosin and microfilaments
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_k0idemdctrvh6fnv0upf5201t4